Dexamethasone palmitate (D-PAL) incorporated into lipid microspheres (
D-PAL emulsion) is taken up by the reticuloendothelial system and by s
ome inflammatory cells. Therefore, it has a stronger anti-inflammatory
activity than free corticosteroids in vivo. To study the effect of D-
PAL emulsion on systemic lupus erythematosus (SLE), we administered D-
PAL emulsion to MRLlpr/lpr mice, an animal model for human SLE. The ef
fect of D-PAL emulsion was compared with that of methylprednisolone (m
-PSL), a water-soluble steroid. Percent survival was higher in the gro
up treated with 0.25 mg of D-PAL emulsion intravenously once every 4 w
eeks than in those groups treated similarly with m-PSL or PBS control.
Swelling of lymph nodes was frequent in the group treated with m-PSL
or with PBS, while rarely observed in the group treated with D-PAL emu
lsion. Proteinuria was more frequent in the groups treated with m-PSL
or PBS than in the group treated with D-PAL emulsion. Although the fre
quency of skin lesions was not different between these three groups, t
he control and m-PSL treated mice had severe skin lesions, such as hai
r loss of erythematous skin with scales and crusts at the nape, while
D-PAL emulsion treated animals showed only facial alopecia without inf
lammatory skin changes. These data demonstrate that D-PAL emulsion was
more effective than a corresponding dose of m-PSL on autoimmune prone
mice. This suggests that intermittent administration of D-PAL emulsio
n may be effective in the treatment of human SLE. (C) 1997 Elsevier Sc
ience Ireland Ltd.